Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chloramphenicol Hemisuccinate
2. Chloramphenicol Monosuccinate
3. Chloramphenicol Succinate Sodium
4. Levomycetin Succinate
1. 982-57-0
2. Chloramphenicol Succinate Sodium
3. Chloramphenicol Monosuccinate Sodium Salt
4. Chloramphenicol Succinate Sodium
5. 872109hx6b
6. Protophenicol
7. Dsstox_cid_4747
8. Dsstox_rid_77520
9. Dsstox_gsid_24747
10. Butanedioic Acid, Mono(2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) Ester, Monosodium Salt, (r-(r*,r*))-
11. Sodium Chloramphenicol Succinate
12. Chloramphenicol Sodium Monosuccinate
13. Cas-982-57-0
14. Sodium 4-((2r,3r)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propoxy)-4-oxobutanoate
15. Ccris 6204
16. Chloramphenicol-sukzinat-natrium
17. Ncgc00094619-04
18. Chloramphenicol Sodium Succinate, D-
19. Einecs 213-568-1
20. Chloramphenicol-sukzinat-natrium [german]
21. Unii-872109hx6b
22. Sodium;4-[(2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoate
23. Chloramphenicol Sodium Succinate [usp:ban:jan]
24. Chloromycetin Succinate (tn)
25. D-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide Alpha-(sodium Succinate)
26. Schembl193134
27. Chloramphenicoli Natrii Succinas
28. Chembl1200729
29. Dtxsid2024747
30. Tox21_113484
31. Akos016340429
32. Tox21_113484_1
33. Ccg-212521
34. Ks-5158
35. Ncgc00094619-06
36. Acetamide, 2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-, Alpha-ester With Sodium Succinate
37. Butanedioic Acid, Mono(2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) Ester, Monosodium Salt, (r-(r(sup *),r(sup *)))(-)
38. Chloramphenicol Sodium Succinate (jp17/usp)
39. Chloramphenicol Sodium Succinate [jan]
40. Chloramphenicol Sodium Succinate [vandf]
41. D02185
42. Chloramphenicol Sodium Succinate [mart.]
43. Chloramphenicol Sodium Succinate [who-dd]
44. Chloramphenicol Sodium Succinate [who-ip]
45. W-100087
46. Chloramphenicol Monosuccinate Sodium Salt [mi]
47. Chloramphenicol Sodium Succinate [ep Monograph]
48. Chloramphenicol Sodium Succinate [orange Book]
49. Chloramphenicoli Natrii Succinas [who-ip Latin]
50. Q27269783
51. Chloramphenicol Sodium Succinate [usp Monograph]
52. Butanedioic Acid, Mono((2r,3r)-2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) Ester, Monosodium Salt
53. D-threo-(-)-2,2-dichloro-n-(.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl)acetamide .alpha.-(sodium Succinate)
54. Sodium4-((2r,3r)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propoxy)-4-oxobutanoate
Molecular Weight | 445.2 g/mol |
---|---|
Molecular Formula | C15H15Cl2N2NaO8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 444.0103151 g/mol |
Monoisotopic Mass | 444.0103151 g/mol |
Topological Polar Surface Area | 162 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 541 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Chloramphenicol sodium succinate |
Drug Label | IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM SUCCINATE.CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE ONLY. IT HAS BEENDEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.1. Chloramphenicol sodium... |
Active Ingredient | Chloramphenicol sodium succinate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1gm base/vial |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
2 of 2 | |
---|---|
Drug Name | Chloramphenicol sodium succinate |
Drug Label | IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM SUCCINATE.CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE ONLY. IT HAS BEENDEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.1. Chloramphenicol sodium... |
Active Ingredient | Chloramphenicol sodium succinate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1gm base/vial |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : Chloramphenicol Succinate
Dosage Form : POWDER FOR SOLUTION FOR INJECTION
Dosage Strength : 1 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Canada
CHLORAMPHENICOL (CHLORAMPHENICOL SODIUM SUCCINATE)
Brand Name : CHLOROMYCETIN SUCCINATE INJECTION
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1G/VIAL
Packaging : 1G
Approval Date :
Application Number : 312363
Regulatory Info :
Registration Country : Canada
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Chloramphenicol Sodium Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chloramphenicol Sodium Succinate, including repackagers and relabelers. The FDA regulates Chloramphenicol Sodium Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chloramphenicol Sodium Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chloramphenicol Sodium Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chloramphenicol Sodium Succinate supplier is an individual or a company that provides Chloramphenicol Sodium Succinate active pharmaceutical ingredient (API) or Chloramphenicol Sodium Succinate finished formulations upon request. The Chloramphenicol Sodium Succinate suppliers may include Chloramphenicol Sodium Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Chloramphenicol Sodium Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chloramphenicol Sodium Succinate written confirmation (Chloramphenicol Sodium Succinate WC) is an official document issued by a regulatory agency to a Chloramphenicol Sodium Succinate manufacturer, verifying that the manufacturing facility of a Chloramphenicol Sodium Succinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chloramphenicol Sodium Succinate APIs or Chloramphenicol Sodium Succinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Chloramphenicol Sodium Succinate WC (written confirmation) as part of the regulatory process.
click here to find a list of Chloramphenicol Sodium Succinate suppliers with Written Confirmation (WC) on PharmaCompass.
Chloramphenicol Sodium Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chloramphenicol Sodium Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chloramphenicol Sodium Succinate GMP manufacturer or Chloramphenicol Sodium Succinate GMP API supplier for your needs.
A Chloramphenicol Sodium Succinate CoA (Certificate of Analysis) is a formal document that attests to Chloramphenicol Sodium Succinate's compliance with Chloramphenicol Sodium Succinate specifications and serves as a tool for batch-level quality control.
Chloramphenicol Sodium Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Chloramphenicol Sodium Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chloramphenicol Sodium Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Chloramphenicol Sodium Succinate EP), Chloramphenicol Sodium Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chloramphenicol Sodium Succinate USP).
LOOKING FOR A SUPPLIER?